These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34106355)

  • 1. Clinico-pathological characteristics of patients with stage IB1-IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan.
    Tsuji K; Shimada M; Takahashi F; Tokunaga H; Deura I; Yamaguchi S; Nakanishi T; Matsuo K; Yaegashi N; Mikami M
    Int J Clin Oncol; 2021 Aug; 26(8):1541-1552. PubMed ID: 34106355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
    Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
    Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of 2018 FIGO stage IB-IIA cervical cancer with absence of high/ intermediate surgical-pathological risk factors.
    Shibuya Y; Shimada M; Tsuji K; Shigeta S; Tanase Y; Matsuo K; Yamaguchi S; Kanao H; Saito T; Mikami M
    Jpn J Clin Oncol; 2022 Nov; 52(11):1289-1296. PubMed ID: 35913375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of survival and adverse events between women with stage IB1 and stage IB2 cervical cancer treated by laparoscopic radical vaginal hysterectomy.
    Hong JH; Choi JS; Lee JH; Son CE; Jeon SW; Bae JW; Eom JM
    Ann Surg Oncol; 2012 Feb; 19(2):605-11. PubMed ID: 21769469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage.
    Balaya V; Guani B; Magaud L; Bonsang-Kitzis H; Ngô C; Mathevet P; Lécuru F; On Behalf Of The Senticol Group
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of recurrence in FIGO stage IB1-IB2 cervical cancer: Comparison between minimally invasive and abdominal radical hysterectomy.
    Corrado G; Anchora LP; Bruni S; Sperduti I; Certelli C; Chiofalo B; Giannini A; D'Oria O; Bizzarri N; Legge F; Cosentino F; Turco LC; Vizza E; Scambia G; Ferrandina G
    Eur J Surg Oncol; 2023 Nov; 49(11):107047. PubMed ID: 37862783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early cervical adenocarcinoma: selection criteria for radical surgery.
    Schorge JO; Lee KR; Lee SJ; Flynn CE; Goodman A; Sheets EE
    Obstet Gynecol; 1999 Sep; 94(3):386-90. PubMed ID: 10472864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?
    Finan MA; DeCesare S; Fiorica JV; Chambers R; Hoffman MS; Kline RC; Roberts WS; Cavanagh D
    Gynecol Oncol; 1996 Aug; 62(2):139-47. PubMed ID: 8751541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical retrospective review of stage IB1 and IB2 cervical cancer].
    Shao S; Sun L; Sun L
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):66-8. PubMed ID: 11776803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals.
    Liu P; Lin L; Kong Y; Huo Z; Zhu L; Bin X; Lang J; Chen C
    BMC Cancer; 2020 Mar; 20(1):189. PubMed ID: 32138718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic results and surgical morbidity of laparoscopic nerve-sparing radical hysterectomy in the treatment of FIGO stage IB cervical cancer: long-term follow-up.
    Park NY; Chong GO; Hong DG; Cho YL; Park IS; Lee YS
    Int J Gynecol Cancer; 2011 Feb; 21(2):355-62. PubMed ID: 21270616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
    Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
    Kim SI; Lee M; Lee S; Suh DH; Kim HS; Kim K; Chung HH; No JH; Kim JW; Park NH; Song YS; Kim YB
    Gynecol Oncol; 2019 Oct; 155(1):75-82. PubMed ID: 31383569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
    Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative treatments for stage IB-IIB uterine cervical cancer.
    Shimada M; Tokunaga H; Kobayashi H; Ishikawa M; Yaegashi N
    Jpn J Clin Oncol; 2020 Feb; 50(2):99-103. PubMed ID: 31868879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
    Takahashi M; Sakai K; Iwasa N; Wada M; Hino M; Kurahashi T; Ueno M; Nakagawa H
    J Obstet Gynaecol Res; 2021 May; 47(5):1871-1877. PubMed ID: 33611822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass predicts the survival of patients with new International Federation of Gynecology and Obstetrics Stage IB1 and IB2 cervical carcinoma treated with radical hysterectomy.
    Finan MA; Hoffman MS; Chambers R; Fiorica JV; DeCesare S; Kline RC; Roberts WS; Cavanagh D
    Cancer; 1998 Jul; 83(1):98-102. PubMed ID: 9655298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.